Patent · US Active

1,2-disubstituted heterocyclic compounds

US8071595B2 · kind B2 · utility

19Cited by

0References

4Claims

0Family size

Assignee

EnVivo Pharmaceuticals, Inc. · US

Inventors

Amy Ripka · Reading, US
Gideon Shapiro · Gainesville, US
Richard Chesworth · Boston, US

Key dates

Filing date	Jun 24, 2009
Grant date	Dec 6, 2011
Priority date	—
Expiry date	Jun 24, 2029

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D471/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

1,2-disubstituted heterocyclic compounds which are inhibitors of phosphodiesterase 10 are described. Also described are processes, pharmaceutical compositions, pharmaceutical preparations and pharmaceutical use of the compounds in the treatment of mammals, including human(s) for central nervous system (CNS) disorders and other disorders which may affect CNS function. Among the disorders which may be treated are neurological, neurodegenerative and psychiatric disorders including, but not limited to, those associated with cognitive deficits or schizophrenic symptoms.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.